Effect of E-BAL on Severity of VAP Assessed Through CPIS on the Patients of Traumatic Brain Injury in Neurocritical Care, Also Effect on Days of Ventilation and ICU Stay.
Effect of Early Bronchoalveolar Lavage on Severity of Ventilator Associated Pneumonia Assessed Through Clinical Pulmonary Infection Score on the Patients of Traumatic Brain Injury in Neurocritical Care.
1 other identifier
interventional
60
1 country
1
Brief Summary
Severe traumatic brain injury (STBI) is a leading cause of disability, mortality, and economic burden worldwide. The impact of severe traumatic brain injury (STBI) on the economy of developing countries like Pakistan is distressing. Pakistan has a large proportion of the young adult population in the World. Motorbike is the most common locomotive vehicle. These young ones are in the economically productive part of their lives. Their loss is an economical set back not only for their families but also for the Nation. Patients with STBI need standardized management in Neuro-critical care unit (NCCU). Although the setup and maintenance cost of an effective NCCU is one of the major burden on the budget of any public sector hospital, but the young survivor in turn can be productive for the Nation. During mechanical ventilation, severe traumatic brain injury patients frequently develop ventilator-associated pneumonia (VAP). Ventilator-associated pneumonia can be evaluated using Clinical pulmonary infection score (CPIS). CPIS is considered as an important clinical indicator of pneumonia in NCCU. Bronchoalveolar Lavage (BAL) is a minimally invasive procedure done with instillation of normal saline into subsegments of the lung followed by suction and collection of the instilled fluid for analysis with flexible bronchoscope. Patients with moderate and severe traumatic brain injury usually present with altered conscious level, and most of them already have aspiration of vomitus, debris and secretions which increase the risk of VAP in them. Bronchoalveolar lavage can be helpful in preventing this dreadful VAP by clearing the airways. The aim of this study is to find out the effect of early Bronchoalveolar Lavage on severity of development of VAP assessed through clinical pulmonary infection score (CPIS) in TBI patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 9, 2021
CompletedFirst Posted
Study publicly available on registry
July 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedJuly 27, 2021
July 1, 2021
7 months
June 9, 2021
July 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
VAP severity
The study will help to figure out the effect of early bronchoalveolar lavage on decreasing the severity of VAP which will be assessed through CPIS
10 days
Ventilation Days
Number of days patient remains on ventilator
up to three weeks
ICU stay Total
Number of days patient remains in ICU
up to four weeks
Study Arms (2)
E-BAL
EXPERIMENTALE-BAL carried out within 48 hours
Conservative/Control
NO INTERVENTIONStandard of care management
Interventions
E-BAL done with instillation of 100cc normal saline and sucked out
Eligibility Criteria
You may qualify if:
- Patients between the age of 15-60 years with traumatic brain injury,
- Presenting GCS between 5 to 10,
- On mechanical ventilation,
- Either gender.
You may not qualify if:
- Patient undergoing neurosurgical procedure.
- Poly trauma.
- An underlying malignancy.
- Patients admitted with any medical comorbidity including known case of restrictive or infiltrative lung disease, chronic liver disease, and chronic kidney failure.
- Patients who expired within 10 days of admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jinnah Hospitallead
Study Sites (1)
Jinnah Hospital
Lahore, Punjab Province, 54550, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Syed S Hussain, MBBS, FCPS
Jinnah Hospital Lahore
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical officer trainee
Study Record Dates
First Submitted
June 9, 2021
First Posted
July 27, 2021
Study Start
June 1, 2021
Primary Completion
December 30, 2021
Study Completion
December 30, 2021
Last Updated
July 27, 2021
Record last verified: 2021-07